📊 OPK Key Takeaways
Is Opko Health, Inc.. (OPK) a Good Investment?
OPKO Health is in severe operational distress with revenue declining 14.9% YoY, massive operating losses of -$117.4M (-19.3% margin), and catastrophic net losses of -$225.7M (-37.2% margin). Most critically, the company is burning cash operationally at -$178.5M with negative free cash flow of -$190.8M, indicating fundamental business model failure. While the balance sheet provides temporary runway, current operational performance is unsustainable and threatens shareholder value.
Why Buy Opko Health, Inc.. Stock? OPK Key Strengths
- Excellent liquidity position with 3.97x current ratio and 3.52x quick ratio
- Strong balance sheet with $364.4M in cash and low leverage (0.27x debt/equity ratio)
- Adequate gross margin of 33.9% suggests some core product viability despite volume declines
OPK Stock Risks: Opko Health, Inc.. Investment Risks
- Revenue declining 14.9% YoY with no apparent turnaround in sight
- Negative operating cash flow of -$178.5M indicates core business is not generating cash
- Massive net losses of -$225.7M deteriorating 324% YoY signals deepening fundamental problems
- Current burn rate unsustainable; cash reserves will be depleted without operational improvement
- Negative operating margin of -19.3% indicates severe cost structure problems relative to revenue
Key Metrics to Watch
- Quarterly revenue trends and growth trajectory reversal
- Operating cash flow stabilization and path to positive territory
- Operating margin improvement and cost structure reduction initiatives
- Cash burn rate and runway extension with current balance sheet
- Product pipeline approvals and new revenue stream launches
Opko Health, Inc.. (OPK) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 3.97x current ratio provides a solid financial cushion.
OPK Profit Margin, ROE & Profitability Analysis
OPK vs Healthcare Sector: How Opko Health, Inc.. Compares
How Opko Health, Inc.. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Opko Health, Inc.. Stock Overvalued? OPK Valuation Analysis 2026
Based on fundamental analysis, Opko Health, Inc.. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Opko Health, Inc.. Balance Sheet: OPK Debt, Cash & Liquidity
OPK Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Opko Health, Inc..'s revenue has declined by 51% over the 5-year period, indicating business contraction. The most recent EPS of $-0.25 indicates the company is currently unprofitable.
OPK Revenue Growth, EPS Growth & YoY Performance
OPK Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $151.7M | $21.6M | $0.03 |
| Q2 2025 | $156.8M | -$10.3M | $-0.01 |
| Q1 2025 | $150.0M | -$67.6M | N/A |
| Q3 2024 | $173.6M | $24.9M | $0.03 |
| Q2 2024 | $182.2M | -$10.3M | N/A |
| Q1 2024 | $173.7M | -$18.3M | N/A |
| Q3 2023 | $178.6M | -$84.5M | N/A |
| Q2 2023 | $265.4M | -$19.6M | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Opko Health, Inc.. Dividends, Buybacks & Capital Allocation
OPK SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Opko Health, Inc.. (CIK: 0000944809)
📋 Recent SEC Filings
❓ Frequently Asked Questions about OPK
What is the AI rating for OPK?
Opko Health, Inc.. (OPK) has an AI rating of STRONG SELL with 85% confidence, based on fundamental analysis of SEC EDGAR filings.
What are OPK's key strengths?
Claude: Excellent liquidity position with 3.97x current ratio and 3.52x quick ratio. Strong balance sheet with $364.4M in cash and low leverage (0.27x debt/equity ratio).
What are the risks of investing in OPK?
Claude: Revenue declining 14.9% YoY with no apparent turnaround in sight. Negative operating cash flow of -$178.5M indicates core business is not generating cash.
What is OPK's revenue and growth?
Opko Health, Inc.. reported revenue of $606.9M.
Does OPK pay dividends?
Opko Health, Inc.. pays dividends, with $4.7M distributed to shareholders in the trailing twelve months.
Where can I find OPK SEC filings?
Official SEC filings for Opko Health, Inc.. (CIK: 0000944809) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is OPK's EPS?
Opko Health, Inc.. has a diluted EPS of $-0.30.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is OPK a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Opko Health, Inc.. has a STRONG SELL rating with 85% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is OPK stock overvalued or undervalued?
Valuation metrics for OPK: ROE of -17.8% (sector avg: 15%), net margin of -37.2% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy OPK stock in 2026?
Our dual AI analysis gives Opko Health, Inc.. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is OPK's free cash flow?
Opko Health, Inc..'s operating cash flow is $-178.5M, with capital expenditures of $12.3M. FCF margin is -31.4%.
How does OPK compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -37.2% (avg: 12%), ROE -17.8% (avg: 15%), current ratio 3.97 (avg: 2).